James E. Flynn 13D/13G Filings for Cullinan Oncology, Inc. (CGEM)

James E. Flynn 13D and 13G filings for Cullinan Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-04-24
5:50 pm
Purchase
2024-04-1813GCullinan Oncology, Inc.
CGEM
James E. Flynn3,283,824
5.710%
3,283,824increase
(New Position)
Filing